Bayer has been ordered by a jury in Georgia to pay approximately $2.1 billion to a plaintiff who alleged that the company’s Roundup weed killer caused his cancer, according to statements from the plaintiff’s legal team late Friday.

The verdict, announced on Saturday by Bayer stated the company intends to appeal. This ranks among the largest damages awarded in a Roundup-related lawsuit.

It represents another significant legal setback for Bayer, one of the world’s leading producers of seeds and pesticides.

Bayer has paid approximately $10 billion to settle numerous lawsuits alleging that its glyphosate-based herbicide, Roundup, causes cancer.

Despite these settlements, over 60,000 additional cases are still pending.

The German pharmaceutical and biotechnology giant, Bayer acquired Roundup through its $63 billion purchase of U.S. agrochemical company Monsanto in 2018.

In a recent Georgia case, a jury awarded $65 million in compensatory damages and $2 billion in punitive damages, according to a statement from the plaintiff’s law firms, Arnold & Itkin LLP and Kline & Specter PC.

Bayer, in a statement, said it disagreed with the jury’s verdict, arguing that it contradicts the overwhelming body of scientific evidence and the consensus of regulatory authorities and their scientific evaluations around the world.

“We believe that we have strong arguments on appeal to get this verdict overturned and the excessive and unconstitutional damage awards eliminated or reduced,” it said.

Bayer noted that in cases where final judgments have been reached, damages have been reduced by 90% on average compared to the original jury awards.